Rymedi is proud to announce its latest partnership with My One Medical Source® (MOMS), an innovative platform empowering labs and other clients to connect with nearly 2,000 independent MAPs: Medical Access Point/Providers.
The MOMS platform enables participants to have convenient specimen collection options expanding the reach for laboratories. Rymedi will power MOMS on its blockchain platform, creating an immutable electronic chain of custody for each step in the sample collection process. Together, they are combining their retrospective strengths to provide participants, laboratories and other stakeholders a consistent experience from order generation, specimen collection and results delivery.
“MOMS is excited to partner with Rymedi and their technologically advanced offerings. Their approach to the ordering process compliments MOMS’ ability to get specimens collected in a unique way from which the industry will benefit,” said Brad Seybert, CEO/Founder of MOMS. “Rymedi aligns with our philosophy that Better Access leads to Better Outcomes, and they provide functionality that drives the mission forward.”
David Stefanich, CEO of Rymedi, expressed his enthusiasm for the collaboration by saying “Rymedi is excited to join forces with My One Medical Source to make lab testing more accessible. Together, we’re creating a more efficient and transparent lab testing experience.”
Rymedi and MOMS will appear together at the HLTH USA conference in Las Vegas October 20 – 23, 2024.
